PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Intensive Care Department, Ministry of the National Guard-Health Affairs, ICU 1425, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia. arabi@ngha.med.sa.\', \'King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa.\', \'King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa.\', \'Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK.\', \'Intensive Care Unit, Imperial College Healthcare NHS Trust, London, UK.\', \'Intensive Care Center, University Medical Center Utrecht, Utrecht, The Netherlands.\', \'Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.\', \'University College Dublin Clinical Research Centre At St Vincents University Hospital, Dublin, Ireland.\', \'The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.\', \'The Alfred Hospital, Melbourne, Australia.\', \'Department of Pediatrics, University of British Columbia, Vancouver, Canada.\', \'Department of Intensive Care, Hôpital Raymond Poincaré (APHP), 92380, Garches, France.\', \'Laboratory of Infection and Inflammation, U1173, School of Medicine Simone Veil, University Versailles Saint Quentin and University Paris Saclay, INSERM, 78423, Montigny le Bretonneux, France.\', \'FHU SEPSIS (Saclay and Paris Seine Nord Endeavour To PerSonalize Interventions for Sepsis) and RHU RECORDS (Rapid rEcognition of CORticosteroiD Resistant Or Sensitive Sepsis), ANR-18-RHUS60004, 92380, Garches, France.\', \'King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.\', \'King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.\', \'Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.\', \'Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.\', \'Medical Research Institute of New Zealand, Wellington, New Zealand.\', \'Berry Consultants, Austin, TX, USA.\', \'St. Michael\'s Hospital Unity Health Toronto, Toronto, Canada.\', \'Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.\', \'Faculty of Health Sciences, University of Bristol, Bristol, UK.\', \'Bristol Hematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.\', \'Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.\', \'Global Coalition for Adaptive Research, San Francisco, CA, USA.\', \'Monash University, Melbourne, Australia.\', \'Department of Infectious Diseases, Alfred Health, Melbourne, Australia.\', \'Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, The Netherlands.\', \'Infectious Disease, Auckland City Hospital, Auckland, New Zealand.\', \'NHS Blood and Transplant, Oxford, UK.\', \'Radcliffe Department of Medicine, University of Oxford, Oxford, UK.\', \'University of Toronto, Toronto, ON, Canada.\', \'Sunnybrook Health Sciences Centre, Toronto, Canada.\', \'Canadian Critical Care Trials Group, Toronto, Canada.\', \'UPMC Health System, Pittsburgh, PA, USA.\', \'University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.\', \'University of Antwerp, Wilrijk, Belgium.\', \'National Intensive Care Surveillance-Mahidol Oxford Research Unit, Colombo, Sri Lanka.\', \'Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.\', \'Critical Care Department, University College Hospital, London, UK.\', \'Auckland District Health Board, Auckland, New Zealand.\', \'UPMC Children\'s Hospital of Pittsburgh, Pittsburgh, PA, USA.\', \'Université de Sherbrooke, Sherbrooke, Canada.\', \'Centre de Recherche du CHU de Sherbrooke, Sherbrooke, Canada.\', \'Peter Munk Cardiac Centre at University Health Network, Toronto, Canada.\', \'Harbor-UCLA Medical Center, Torrance, CA, USA.\', \'Intensive Care Unit, Fiona Stanley Hospital, Perth, Australia.\', \'Intensive Care Unit, St. John of God Hospital Subiaco, Perth, Australia.\', \'School of Medicine, University of Western Australia, Perth, Australia.\', \'Computer Science, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Wellcome-Wolfson Institute for Experimental Medicine, Queen\'s University Belfast, Belfast, Northern Ireland, UK.\', \'Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK.\', \'Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.\', \'Microbiology Laboratory, Middlemore Hospital, Auckland, New Zealand.\', \'Clinical Trials Unit, Intensive Care National Audit and Research Centre, London, UK.\', \'Pharmacy Department, Fiona Stanley Hospital, Perth, Australia.\', \'School of Nursing, The University of Auckland, Auckland, New Zealand.\', \'School of Pharmacy, University of Sydney, Sydney, Australia.\', \'Department of Pharmacy, Royal Prince Alfred Hospital, Sydney, Australia.\', \'Intensive Care National Audit and Research Centre (ICNARC), London, UK.\', \'Critical Care Medicine, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'School of Immunology and Microbial Sciences, King\'s College London, London, UK.\', \'Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.\', \'Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.\', \'Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Laval University, Quebec City, QC, Canada.\', \'Population Health and Optimal Health Practices Research Unit, Trauma-Emergency-Critical Care Medicine, CHU de Québec-Université Laval Research Center, Quebec City, QC, Canada.\', \'Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands.\', \'Critical Care Department, University of Manitoba, Winnipeg, Canada.\', \'Department of Surgery, University of Toronto, Toronto, Canada.\', \'Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00134-021-06448-5
?:doi
?:hasPublicationType
?:journal
  • Intensive care medicine
is ?:pmid of
?:pmid
?:pmid
  • 34251506
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.293
?:rankingScore_hIndex
  • 170
is ?:relation_isRelatedTo_publication of
?:title
  • Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all